Literature DB >> 26597269

A Cohort Study for Derivation and Validation of Early Detection of Pancreatic Fistula After Pancreaticoduodenectomy.

Kazuki Takeishi1,2, Takashi Maeda3, Yo-Ichi Yamashita4,3, Eiji Tsujita3, Shinji Itoh4, Norifumi Harimoto4, Toru Ikegami4, Tomoharu Yoshizumi4, Ken Shirabe4, Yoshihiko Maehara4.   

Abstract

BACKGROUND: Pancreatic fistula (PF) remains the most important morbidity after pancreaticoduodenectomy (PD). Early drain removal was recently recommended. However, this is not applicable to all cases because the development of severe PF may not be obvious until a later postoperative day (POD). This study aimed to discover ways to detect clinically relevant PF early during the postoperative stage after PD.
METHODS: We studied 120 patients who underwent PD. Grades B/C PF classified according to the International Study Group of Pancreatic Surgery guidelines were defined as clinically relevant PF. Logistic regression was used to identify detection factors for clinically relevant PF. Receiver operating characteristic curves were used to identify the optimal cutoff value for clinically relevant PF, and the k-fold cross-validation model to validate the cutoff value.
RESULTS: Drain amylase on POD 1 and C-reactive protein (CPR) on POD 2 were independent factors for clinically relevant PF. Drain amylase >1300 IU/l on POD 1 and CRP >12.8 g/dl on POD 2 were the best cutoff values for clinically relevant PF detection and were confirmed by k-fold cross-validation. The sensitivity and specificity values were 79 and 81 %, respectively.
CONCLUSIONS: Values of drain amylase and CRP combined were useful to distinguish clinically relevant PF.

Entities:  

Keywords:  Amylase; C-reactive protein; Pancreatic fistula; Pancreaticoduodenectomy

Mesh:

Substances:

Year:  2015        PMID: 26597269     DOI: 10.1007/s11605-015-3030-x

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN: 1091-255X            Impact factor:   3.452


  30 in total

1.  Predictive risk factors for clinically relevant pancreatic fistula analyzed in 1,239 patients with pancreaticoduodenectomy: multicenter data collection as a project study of pancreatic surgery by the Japanese Society of Hepato-Biliary-Pancreatic Surgery.

Authors:  Manabu Kawai; Satoshi Kondo; Hiroki Yamaue; Keita Wada; Keiji Sano; Fuyuhiko Motoi; Michiaki Unno; Sohei Satoi; A-Hon Kwon; Takashi Hatori; Masakazu Yamamoto; Joe Matsumoto; Yoshiaki Murakami; Ryuichiro Doi; Masahiro Ito; Shuichi Miyakawa; Hiroyuki Shinchi; Shoji Natsugoe; Hisatoshi Nakagawara; Tetsuo Ohta; Tadahiro Takada
Journal:  J Hepatobiliary Pancreat Sci       Date:  2011-07       Impact factor: 7.027

2.  External pancreatic duct stent decreases pancreatic fistula rate after pancreaticoduodenectomy: prospective multicenter randomized trial.

Authors:  Patrick Pessaux; Alain Sauvanet; Christophe Mariette; François Paye; Fabrice Muscari; Antonio Sa Cunha; Bernard Sastre; Jean-Pierre Arnaud
Journal:  Ann Surg       Date:  2011-05       Impact factor: 12.969

3.  Perioperative Enteral Immunonutrition Modulates Systemic and Mucosal Immunity and the Inflammatory Response in Patients With Periampullary Cancer Scheduled for Pancreaticoduodenectomy: A Randomized Clinical Trial.

Authors:  Numan Hamza; Ammar Darwish; Derek A O'Reilly; John Denton; Aali J Sheen; David Chang; David J Sherlock; Basil J Ammori
Journal:  Pancreas       Date:  2015-01       Impact factor: 3.327

4.  Options and limitations in applying the fistula classification by the International Study Group for Pancreatic Fistula.

Authors:  Florian Gebauer; Katja Kloth; Michael Tachezy; Yogesh K Vashist; Guellue Cataldegirmen; Jakob R Izbicki; Maximilliam Bockhorn
Journal:  Ann Surg       Date:  2012-07       Impact factor: 12.969

5.  Outcome of pancreaticoduodenectomy with pylorus preservation or with antrectomy in the treatment of chronic pancreatitis.

Authors:  R E Jimenez; C Fernandez-del Castillo; D W Rattner; Y Chang; A L Warshaw
Journal:  Ann Surg       Date:  2000-03       Impact factor: 12.969

6.  How do we predict the clinically relevant pancreatic fistula after pancreaticoduodenectomy?--an analysis in 244 consecutive patients.

Authors:  Manabu Kawai; Masaji Tani; Seiko Hirono; Shinomi Ina; Motoki Miyazawa; Hiroki Yamaue
Journal:  World J Surg       Date:  2009-12       Impact factor: 3.352

7.  Risk factors for and management of delayed intraperitoneal hemorrhage after pancreatic and biliary surgery.

Authors:  Yo-ichi Yamashita; Akinobu Taketomi; Kengo Fukuzawa; Eiji Tsujita; Norifumi Harimoto; Dai Kitagawa; Yosuke Kuroda; Hiroto Kayashima; Kenzo Wakasugi; Yoshihiko Maehara
Journal:  Am J Surg       Date:  2007-04       Impact factor: 2.565

8.  Diagnostic value of abdominal drainage in individual risk assessment of pancreatic fistula following pancreaticoduodenectomy.

Authors:  C Ansorge; J Z Nordin; L Lundell; L Strömmer; E Rangelova; J Blomberg; M Del Chiaro; R Segersvärd
Journal:  Br J Surg       Date:  2013-12-05       Impact factor: 6.939

9.  Impact of day 2 C-reactive protein on day 3 and 4 thresholds associated with infective complications following curative surgery for colorectal cancer.

Authors:  Michelle L Ramanathan; Graham Mackay; Jonathan Platt; Paul G Horgan; Donald C McMillan
Journal:  World J Surg       Date:  2013-11       Impact factor: 3.352

10.  Utility of drain fluid amylase measurement on the first postoperative day after pancreaticoduodenectomy.

Authors:  Robert P Sutcliffe; Narendra Battula; Ali Haque; Amir Ali; Parthi Srinivasan; Simon W Atkinson; Mohamed Rela; Nigel D Heaton; Andreas A Prachalias
Journal:  World J Surg       Date:  2012-04       Impact factor: 3.352

View more
  1 in total

Review 1.  Predictive value of drain pancreatic amylase concentration for postoperative pancreatic fistula on postoperative day 1 after pancreatic resection: An updated meta-analysis.

Authors:  Yao Liu; Yang Li; Ling Wang; Ci-Jun Peng
Journal:  Medicine (Baltimore)       Date:  2018-09       Impact factor: 1.817

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.